The project has resulted in a novel and reproducible extraction method for causerine, which is compliant with food regulations. The extract is currently being investigated for immunomodulatory properties, in particular its effects on Th1 and Th2 immune responses, as an advanced nutritional adjunct to flu vaccination campaigns.


Activities are planned to develop a novel, IP protected combination of pre- and probiotics targeting gastrointestinal diseases.